Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
RESEARCH TOOLSreports
Holding EYPT?
Track your performance easily
See the Price Targets and Ratings of:
EYPT Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
EYPT Stock 12 Month Forecast
Average Price Target
$28.75
▲(147.21% Upside)
| Highest Price Target$45.00 | Average Price Target$28.75 | Lowest Price Target$15.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
11/07/24
Scotiabank
Reiterated
10/29/24
JonesTrading
Reiterated
10/28/24
Capital One Financial
Assigned
10/28/24
H.C. Wainwright
Reiterated
10/25/24
Robert W. Baird
Reiterated
10/24/24
Mizuho Securities
Reiterated
10/10/24
Jefferies
Reiterated
08/28/24
J.P. Morgan
Reiterated
08/13/24
Guggenheim
Reiterated
06/27/24
Laidlaw
$50
Buy
329.92%
Upside
Reiterated
06/26/24
Laidlaw reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)Laidlaw analyst Yale Jen reiterated a Buy rating and $50.00 price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT).
Chardan Capital
$39→$28
Buy
140.76%
Upside
Reiterated
05/07/24
EyePoint price target lowered to $28 from $39 at ChardanEyePoint price target lowered to $28 from $39 at Chardan
Cantor Fitzgerald
$28
Buy
140.76%
Upside
Reiterated
03/05/24
EyePoint share weakness a buying opportunity, says Cantor FitzgeraldEyePoint share weakness a buying opportunity, says Cantor Fitzgerald
Best Analysts Covering EyePoint Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy EYPT and Sell After:
1 Month
xxx
Success Rate
7/13 ratings generated profit
Average Return
-3.42%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of -3.42% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
Average Return
+41.35%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +41.35% per trade.
1 Year
Success Rate
5/7 ratings generated profit
Average Return
+2.67%
assigned a buy rating 13 days ago
Copying Tim Chiang's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +2.67% per trade.
2 Years
xxx
Success Rate
5/7 ratings generated profit
Average Return
+2.67%
assigned a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +2.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
EYPT Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
23
26
18
15
9
Buy
2
3
3
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
29
21
17
10
Each month's total comprises the sum of three months' worth of ratings.
EYPT Financial Forecast
EYPT Stock Forecast FAQ
What is EYPT’s average 12-month price target, according to analysts?
Based on analyst ratings, EyePoint Pharmaceuticals Inc’s 12-month average price target is $28.75.
What is EYPT’s upside potential, based on the analysts’ average price target?
EyePoint Pharmaceuticals Inc has 147.21% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EYPT a Buy, Sell or Hold?
EyePoint Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is EyePoint Pharmaceuticals Inc’s price target?
The average price target for EyePoint Pharmaceuticals Inc is $28.75. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $15.00. The average price target represents 147.21% Increase from the current price of $11.63.
The highest analyst price target is $45.00 ,the lowest forecast is $15.00. The average price target represents 147.21% Increase from the current price of $11.63.
What do analysts say about EyePoint Pharmaceuticals Inc?
EyePoint Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of EYPT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.